Feroci Francesco, Rettori Marco, Borrelli Andrea, Coppola Angela, Castagnoli Antonio, Perigli Giuliano, Cianchi Fabio, Scatizzi Marco
Department of General Surgery, Misericordia e Dolce Hospital, Prato, Italy.
Department of General Surgery, Misericordia e Dolce Hospital, Prato, Italy.
Surgery. 2014 Mar;155(3):529-40. doi: 10.1016/j.surg.2013.10.017. Epub 2013 Oct 16.
Our aim was to perform a meta-analysis of high-quality published trials, randomized and observational, comparing total thyroidectomy (TT) and bilateral subtotal thyroidectomy (ST) for Graves' disease.
All studies published from 1970 to August 2012 were identified. All randomized controlled trials (RCTs) were included. Selection of high-quality, nonrandomized comparative studies (NRCTs) was based on a validated tool (Methodological Index for Nonrandomized Studies). Recurrent hyperthyroidism during follow-up, progression of ophthalmopathy, postoperative temporary and permanent hypoparathyroidism, and permanent recurrent laryngeal nerve (RLN) palsy were compared using odds ratios (ORs).
Twenty-three studies were included (4 RCTs and 19 NRCTs) compromising 3,242 patients (1,665 TT, 1,577 ST). TT was associated with a decrease in recurrent hyperthyroidism (P < .00001; OR, 0.10; 95% confidence interval [CI], 0.06-0.18), but with an increase in both temporary (P < .00001; OR, 2.70; 95% CI, 2.04-3.56) and permanent hypoparathyroidism (P = .005; OR, 2.91; 95% CI, 1.59-5.32). Progression of ophthalmopathy (P = .76; OR, 0.90; 95% CI, 0.48-1.71) and permanent RLN palsy (P = .82; OR, 0.91; 95% CI, 0.41-2.02) were similar.
TT offers a better chance of cure of hyperthyroidism than bilateral ST and can be accomplished safely with only a small increase in temporary and permanent hypoparathyroidism.
我们的目的是对已发表的高质量随机和观察性试验进行荟萃分析,比较甲状腺全切除术(TT)和双侧甲状腺次全切除术(ST)治疗格雷夫斯病的效果。
确定了1970年至2012年8月发表的所有研究。纳入了所有随机对照试验(RCT)。基于一种经过验证的工具(非随机研究方法学指数)选择高质量的非随机对照研究(NRCT)。使用比值比(OR)比较随访期间复发性甲亢、眼病进展、术后暂时性和永久性甲状旁腺功能减退以及永久性喉返神经(RLN)麻痹。
纳入了23项研究(4项RCT和19项NRCT),涉及3242例患者(1665例行TT,1577例行ST)。TT与复发性甲亢的减少相关(P <.00001;OR,0.10;95%置信区间[CI],0.06 - 0.18),但与暂时性(P <.00001;OR,2.70;95%CI,2.04 - 3.56)和永久性甲状旁腺功能减退的增加相关(P =.005;OR,2.91;95%CI,1.59 - 5.32)。眼病进展(P =.76;OR,0.90;95%CI,0.48 - 1.71)和永久性RLN麻痹(P =.82;OR,0.91;95%CI,0.41 - 2.02)相似。
与双侧ST相比,TT治愈甲亢的机会更好,并且可以安全完成,只是暂时性和永久性甲状旁腺功能减退略有增加。